Antidepressant treatment outcomes in family medicine
- Subhija Prasko
(Family Medicine Teaching Centre, Primary Health Care Zenica, Zenica, Bosnia and Herzegovina)
- Nurka Pranjić (School of Medicine, University of Tuzla, Tuzla, Department of Occupational Medicine, Bosnia and Herzegovina)
- Larisa Gavran (Family Medicine Teaching Centre, Primary Health Care Zenica, Zenica, Bosnia and Herzegovina)
- Alma Alić (Family Medicine Teaching Centre, Primary Health Care Zenica, Zenica, Bosnia and Herzegovina)
- Ibrahim Gledo (Family Medicine Teaching Centre, Primary Health Care Zenica, Zenica, Bosnia and Herzegovina)
- Enisa Ramić (Primary Health Care Centre and Polyclinic ‘’Dr Mustafa Šehovic’’, Tuzla, Department of Family Medicine, Bosnia and Herzegovina)
- Emina Spahić (School of Medicine, University of Sarajevo, Sarajevo, Department of Forensic Medicine, Bosnia and Herzegovina)
- Erna Prasko (Family Medicine Teaching Centre, Primary Health Care Zenica, Zenica, Bosnia and Herzegovina)
- Irma Ramić (Specialized Hospital Heart Centre, Sarajevo, Sarajevo, Bosnia and Herzegovina)
Abstract
Aim: To determine the prevalence of depressive episodes and recurrent depressive disorders despite of the length of therapy and type of antidepressants.
Methods: The study was conducted among 508 patients aged 19-65 years who were treated for depression for at least 3 months (mild and moderate episodes were controlled and the effects of treatment monitored by family physicians, while severe episodes were controlled by a psychiatrist) during 2013- 2015 in Zenica-Doboj Canton using the Hamilton Depression Rating Scale (HDRS).
Results: The average age of the patients was 48.98±11.585 years. Depressive disorder was most commonly represented in patients with high-level education, 22%, more frequently in non-productive workers (non-productive vs. manufacturing 58%:35%). A significant number of patients who were treated for depression were unemployed (57%). All respondents were suffering from the most serious episode of depression with an average depression rate at the Hamilton scale 18.49±8.603, with a very serious depression level of 32%, severe 17%, moderate 21%, and mild 20%. Most patients were treated with paroxetine, 27%, fluoxetine 22% and sertraline 17%. Efficacy of depression treatment with different types of selective serotonin reuptake inhibitors antidepressants (SSRIs) was not significantly different (p=0.502).
Conclusion: Success of the treatment with the absence of symptoms of depression was achieved in 10% and the maintenance of depressive episodes occurred in 90% of cases. Adverse reactions with the most commonly prescribed SSRI in our country should be important in creating procedures and strategies for the future treatment of depression in family medicine.
Keywords: depressive episodes, effects of medications, antidepressant side effects, general practitioners, recurrent depressive disorders
How to Cite:
Prasko, S., Pranjić, N., Gavran, L., Alić, A., Gledo, I., Ramić, E., Spahić, E., Prasko, E. & Ramić, I., (2019) “Antidepressant treatment outcomes in family medicine”, Medicinski glasnik 16(2), 333-337. doi: https://doi.org/10.17392/1025-19
Downloads:
Download PDF
View PDF
0 Views
0 Downloads